Delivery Order SPE2DB22D1017-SPE2DB24FG3WK
Award Date
8/23/24
Potential Completion Date
8/26/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,573.45, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, with an ultimate completion date of September 13, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product. The $15,436.60 fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency customer for Amerisourcebergen. The contract has an ultimate completion date of September 3, 2024 and was awarded on August 30, 2024. This award is likely part of a larger indefinite...
This federal contract award, valued at $1,577.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product, with a completion date of August 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $2,681.73, is for the delivery of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of...
This federal contract award, valued at $4,988.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of fluticasone propionate HFA 220 mcg 12 g inhalers, with an ultimate completion date of September 30, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,047,320 units of the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The $7,826.62 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. This contract is not a set-aside and is part of a larger Indefinite...
This federal contract award, valued at $1,115.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for FLUTICASONE PROP HFA 110 MCG 12GM, a pharmaceutical product, with an ultimate completion date of August 14, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $3,371.32 and covers the delivery of Fluticasone Prop HFA 44 MCG 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $6,599.63 for the supply of Fluticasone Prop HFA 220 MCG 12GM. The contract was awarded by the Defense Logistics Agency (DLA), with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of December 23, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...